Port-site recurrence in a patient undergoing robotic hysterectomy and lymph node dissection for endometrioid adenocarcinoma of the uterus.

Gynecol Oncol Case Rep · 2013 · PMC3862220 · PMID 24371704

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

Therefore, the impact of the port site metastatic tumor on the outcome may not be significant and the benefit from any preventive measures may be limited.

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.